Quality colonoscopy and risk of interval cancer in Lynch syndrome

International Journal of Colorectal Disease

Volumn 28, Issue 12, 2013, Pages 1643-1649

  Haanstra, J F ^a,d   Vasen, H F A ^b,e   Sanduleanu, S ^c   Van Der Wouden, E J ^a   Koornstra, J J ^d   Kleibeuker, J H ^d   De Vos Tot Nederveen Cappel, W H ^a  

^a ISALA HOSPITAL   (Netherlands)

^b Netherlands Foundation for the Detection of Hereditary Tumors   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colonoscopy; Interval cancer; Lynch syndrome; Quality; Surveillance

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COLON ADENOMA; COLONOSCOPY; CONTROLLED STUDY; FEMALE; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERVAL CANCER; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; MIDDLE AGED; NETHERLANDS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION;

ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 84889877990     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-013-1745-2     Document Type: Article

References (42)

1. Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe 2004. Ann Oncol 16:481-8
2. Lemmens VEPP, Coeberg JWW (2006) Epidemiologie van colorectale tumoren. IKR Bulletin 30:4-7
3. Hampel H, Frankel WL, Martin E et al (2005) Screening for the Lynch syndrome (hereditary non polyposis colorectal carcinoma). N Engl J Med 352:1851-1860
4. Lynch HT, Lynch PM, Lanspa SJ et al (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76:1-18
5. Hampel H, Frankel WL, Martin E et al (2008) Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26:5783-5788
6. Vasen HF, Wijnen JT, Menko FH et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020-1027
7. Koornstra JJ, Mourits MJ, Sijmons RH et al (2009) Management of extracolonic tumours in patients with Lynch syndrome. Lancet Oncol 10:400-408
8. Fitzgibbons RJ Jr, Lynch HT, Stanislav GV et al (1987) Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg 206:289-295
9. Shashidharan M, Smyrk T, Lin KM et al (1999) Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population. Dis Colon Rectum 42:722-726
10. Lindor NM, Petersen GM, Hadley DW et al (2006) Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296:1507-1517
11. Vasen HF, Abdirahman M, Brohet R et al (2010) One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 138:2300-2306
12. de Jong AE, Hendriks YM, Kleibeuker JH et al (2006) Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 130:665-671
13. Jarvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834
14. Renkonen-Sinisalo L, Aarnio M, Mecklin JP et al (2000) Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect Prev 24:137-142
15. Mecklin JP, Aarnio M, Laara E et al (2007) Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology 133:1093-1098
16. Engel C, Rahner N, Schulmann K et al (2010) Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 8:174-182
17. Stuckless S, Green JS, Morgenstern M et al (2012) Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation. Clin Genet 82:439-445
18. de Jong AE, Nagengast FM, Kleibeuker JH et al (2006) What is the appropriate screening protocol in Lynch syndrome? Fam Cancer 5:373-378
19. Vasen HF, den Hartog Jager FC, Menko FH et al (1989) Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in the Netherlands. Am J Med 86:278-281
20. Plaschke J, Engel C, Kruger S et al (2004) Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations; the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22:4486-4494
21. Ramsoekh D, Wagner A, van Leerdam ME et al (2009) Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management. Hered Cancer Clin Pract 7:17
22. Jass JR (2000) Pathology of hereditary nonpolyposis colorectal cancer. Ann N Y Acad Sci 910:62-73
23. Vasen HF, Nagengast FM, Khan PM (1995) Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 345:1183-1184
24. de Jong AE, Morreau H, van Puijenbroek M et al (2004) The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 126:42-48
25. Rijcken FE, Hollema H, Kleibeuker JH (2002) Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 50:382-386
26. Rondagh EJ, Bouwens MW, Riedl RG et al (2012) Endoscopic appearance of proximal colorectal neoplasms and potential implications for colonoscopy in cancer prevention. Gastrointest Endosc 75:1218-1225
27. le Clercq C, Rondagh E, Riedl R et al (2011) Interval colorectal cancers frequently have subtle macroscopic appearance: a 10 year-experience in an academic center. Gastroenterology 140:S112-S113
28. Thuraisingam AI, Brown JL, Anderson JT (2008) What are the sensitivity and specificity of endoscopic photographs in determining completion of colonoscopy? Results from an online questionnaire. Eur J Gastroenterol Hepatol 20:567-571
29. Powell N, Knight H, Dunn J et al (2011) Images of the terminal ileum are more convincing than cecal images for verifying the extent of colonoscopy. Endoscopy 43:196-201
30. van Vugt van Pinxteren MW, van Kouwen MC, van Oijen MG et al (2012) A prospective study of bowel preparation for colonoscopy with polyethylene glycol-electrolyte solution versus sodium phosphate in Lynch syndrome: a randomized trial. Fam Cancer 11:337-341
31. Chai H, Brown RE (2009) Field effect in cancer - an update. Ann Clin Lab Sci 39:331-7
32. Rex DK (2006) Maximizing detection of adenomas and cancers during colonoscopy. Am J Gastroenterol 101:2866-2877
33. Vasen HFA, Blanco I, Aktan-Collan K et al (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62:812-823. doi: 10.1136/gutjnl-2012-304356
34. Haanstra JF, de Vos Tot Nederveen Cappel WH, Gopie JP et al (2012) Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy. Dis Colon Rectum 55:653-9
35. Lai EJ, Calcerwood AH, Doros G et al (2009) The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc 69:620-625
36. Brown SR, Baraza W (2010) Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum. Cochrane Database Syst Rev 10, CD006439
37. Huneburg R, Lammert F, Rabe C et al (2009) Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Endoscopy 41:316-322
38. Hurlstone DP, Karajeh M, Cross SS et al (2005) The role of high-magnification-chromoscopic colonoscopy in hereditary nonpolyposis colorectal cancer screening: a prospective "back-to-back" endoscopic study. Am J Gastroenterol 100:2167-2173
39. Lecomte T, Cellier C, Meatchi T et al (2005) Chromoendoscopic colonocopy for detection preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol 3:897-902
40. Stoffel EM, Turgeon DK, Stockwell DH et al (2008) Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila) 1:507-513
41. Stoffel EM, Turgeon DK, Stockwell DH et al (2008) Missed adenomas during colonoscopic surveillance in individuals with Lynch syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila) 1:470-475
42. Haanstra JF, Kleibeuker JH, Koornstra JJ (2013) Role of new endoscopic techniques in Lynch syndrome. Fam Canc. doi: 10.007/s10689-013-9610-6